Tuberculosis Infection and Incidence of Loss to Follow Up among HIV Patients at Saiful Anwar General Hospital, Indonesia: A Retrospective Study
Main Article Content
Abstract
Introduction: Tuberculosis (TB) is the most common opportunistic infection experienced by HIV patients that can affect the success of antiretroviral (ARV) therapy. This study aimed to determine the association between tuberculosis infection and loss to follow-up (LTFU) among HIV patients after ARV therapy initiation. Methods: This retrospective cohort study was conducted by observing HIV patients in Saiful Anwar General Hospital, Indonesia who were diagnosed in 2015 for 39 months based on medical records data. The number of samples that met the inclusion and exclusion criteria was 170 patients. Kaplan Meier and Cox Regression were the statistical tests used to analyze data in this study. Results: The probability of HIV patients to retain in ARV therapy for 39 months was 90% among HIV co-infected TB patients and 84% among HIV without TB co-infection. However, no significant difference was found (p-value = 0.41). Most of the incidence of LTFU in both groups occurred in the first year after ARV initiation. Cox Regression analysis showed that TB infection did not have a significant relationship with the incidence of LTFU ARV therapy (HR 0.62; 95% CI 0.18 – 2.08; p-value = 0.44). Conclusion: This study found that TB infection did not have a significant association with LTFU after ARV initiation. However, most of LTFU in both groups (the co-infection group and without TB co-infection) occurred in the first year of ARV therapy. Providing intensive counseling in the initial phase could increase the commitment of HIV patients for staying in ARV therapy.
Downloads
Article Details
References
UNAIDS. Global HIV & AIDS statistics - 2020 fact sheet [Internet]. 2020 [cited 2020 Sep 9]. Available from: https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf
World Health Organization. HIV-Associated Tuberculosis [Internet]. 2019. Available from: https://www.who.int/tb/areas-of-work/tb-hiv/tbhiv_factsheet.pdf
Gezae KE, Abebe HT, Gebretsadik LG. Incidence and predictors of LTFU among adults with TB / HIV co-infection in two governmental hospitals , Mekelle , Ethiopia , 2009 – 2016 : survival model approach. BMC Infect Dis [Internet]. 2019;19(107). doi:10.1186/s12879- 019-3756-2
UNAIDS. Global HIV & AIDS Statistics — 2019 Fact Sheet [Internet]. 2019 [cited 2020 Sep 9]. Available from: https://www.unaids.org/en/resources/fact-sheet
World Health Organization. Kajian Nasional Respon HIV di Bidang Kesehatan Republk Indonesia [Internet]. Geneva; 2017. Available from: https://www.who.int/docs/default-source/searo/indonesia/non-who-publications/2017-hiv-country-review-indonesia-bahasa.pdf?sfvrsn=76ccal118_2
World Health Organization. HIV/AIDS [Internet]. 2020 [cited 2020 Sep 9]. Available from: https://www.who.int/news-room/fact-sheets/detail/hiv-aids
World Health Organization. Global report on early warning indicators of hiv drug resistance: technical report, July 2016. Geneva; 2016.
Opio D, Semitala FC, Kakeeto A, Sendaula E, Okimat P, Nakafeero B, et al. Loss to follow-up and associated factors among adult people living with HIV at public health facilities in Wakiso district, Uganda: a retrospective cohort study. 2019;6:1– 10.
Balogun M, Meloni ST, Igwilo UU, Roberts A, Okafor I, Sekoni A, et al. Status of HIV-infected patients classified as lost to follow up from a large antiretroviral program in southwest Nigeria. PLoS One. 2019;14(7):e0219903.
Okoboi S, Ding E, Persuad S, Wangisi J, Birungi J, Shurgold S, et al. Community-based ART distribution system can effectively facilitate long - term program retention and low - rates of death and virologic failure in rural Uganda. AIDS Res Ther. 2015;12(37).
Zhou J, Tanuma J, Chaiwarith R, Lee CKC, Law MG, Kumarasamy N, et al. Loss to Followup in HIV-Infected Patients from Asia-Pacific Region : Results from TAHOD. AIDS Res Treat. 2012;
Mata NLD La, Ly PS, Nguyen K Van, Merati TP, Pham TT, Lee MP, et al. Loss to follow-up trends in HIV-positive patients receiving antiretroviral treatment in Asia from 2003 to 2013. J Acquir Immune Defic Syndr. 2018;74(5):555–62.
Zürcher K, Mooser A, Anderegg N, Tymejczyk O, J.Couvillon M, Nash D, et al. Outcomes of HIV-positive patients lost to follow-up in African treatment programmes. Trop Med Int Heal. 2017;22(4):375–87.
Rachlis B, Ochieng D, Geng E, Rotich E, Ochieng V, Maritim B, et al. Evaluating outcomes of patients lost to follow-up in a large comprehensive care treatment program in western Kenya. J Acquir Immune Defic Syndr. 2015;68(4):e46–e55.
Basset I V, Chetty S, Wang B, Mazibuko M, Giddy J, Lu Z, et al. Loss to follow-up and mortality among HIV-infected people coinfected with TB at ART initiation in Durban, South Africa. J Acquir Immune Defic Syndr. 2012;59(1):25–30.
Tran DA, Ngo AD, Shakeshaft A, Wilson DP, Doran C. Trends in and Determinants of Loss to Follow Up and Early Mortality in a Rapid Expansion of the Antiretroviral Treatment Program in Vietnam : Findings from 13 Outpatient Clinics. PLoS One. 2013;8(9):e73181.
Alvarez-uria G, Naik PK, Pakam R, Midde M. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India. Glob Health Action. 2013;6(21682):1–8.
Cuong DD, Thorson A, Sönnerborg A, Hoa NP, Chuc NTK, Phuc HD, et al. Survival and causes of death among HIV-infected patients starting antiretroviral therapy in north-eastern Vietnam. Scand J Infect Dis. 2012;44(3):201–8.
Matsumoto S, Tanuma J, Mizushima D, Chi N, Nguyen T, Thuy T, et al. High Treatment Retention Rate in HIV- Infected Patients Receiving Antiretroviral Therapy at Two Large HIV Clinics in Hanoi ,. PLoS One. 2015;10(9):e0139594.
Reepalu A, Balcha TT, Sturegård E, Medstrand P, Björkman P. Long-term Outcome of Antiretroviral Treatment in Patients With and Without Concomitant Tuberculosis Receiving Health Center – Based Care — Results From a Prospective Cohort Study. Open Forum Infect Dis. 2017;1–8.
Berheto TM, Haile DB, Mohammed S. Predictors of Loss to follow-up in Patients Living with HIV/ AIDS after Initiation of Antiretroviral Therapy. N Am J Med Sci. 2014;6(9):453–9.
Mekonnen N, Abdulkadir M, Shumetie E, Baraki AG. Incidence and predictors of loss to follow - up among HIV infected adults after initiation of first line anti - retroviral therapy at University of Gondar comprehensive specialized Hospital Northwest Ethiopia , 2018 : retrospective follow up study. BMC Res Notes [Internet]. 2019;12(111). doi:10.1186/s13104-019-4154-y
Kiwanuka J, Waila JM, Kahungu MM, Kitonsa J, Kiwanuka N. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting : A retrospective cohort study in Masaka ,. PLoS One [Internet]. 2020;15(4):e0217606. doi:10.1371/journal.pone.0217606
Ajmala IE, Wulandari L. Terapi ARV pada Penderita Ko-Infeksi TB-HIV. J Respirasi. 2015;1(1):22–8.
Kementerian Kesehatan Republik Indonesia. Manajemen pelaksanaan kolaborasi TB-HIV di Indonesia. Jakarta, Indonesia: Direktorat Jenderal Pengendalian Penyakit dan Penyehatan Lingkungan; 2011.
World Health Organization. Global tuberculosis report 2019. Geneva: World Health Organization; 2019.
Kementerian Kesehatan RI. Sekretariat Jenderal. Profil Kesehatan Indonesia Tahun 2019. Jakarta: Kementerian Kesehatan RI; 2019.
Assemie MA, Muchie KF, Ayele TA. Incidence and predictors of loss to follow up among HIV - infected adults at Pawi General Hospital , northwest Ethiopia : competing risk regression model. BMC Res Notes [Internet]. 2018;11(287). Available from: https://doi.org/10.1186/s13104-018-3407-5
World Health Organization. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV- related disease in adults and children. Geneva, Switzerland: World Health Organization; 2007.
Birhanu A, Id T, Tsegaye AT, Wolde HF. Incidence and predictors of loss to follow up among adult HIV patients on antiretroviral therapy in University of Gondar Comprehensive Specialized Hospital : A competing risk regression modeling. PLoS One [Internet]. 2020;15(1):e0227473. doi:10.1371/journal.pone.0227473
Kementerian Kesehatan Republik Indonesia. Petunjuk teknis pengisian format pencatatan dan pelaporan pasien HIV/AIDS. Jakarta: Kementerian Kesehatan Republik Indonesia; 2015.
Yende-zuma N, Naidoo K, Africa S, Africa S. The effect of timing of initiation of ART on loss to follow up in HIV-TB co infected patients in South Africa: An open label randomized controlled trial. J Acquir Immune Defic Syndr. 2016;72(4):430–6.
Mutembo S, Mutanga JN, Musokotwane K, Alisheke L, Whalen CC. Antiretroviral therapy improves survival among TB-HIV co-infected patients who have CD4 + T-cell count above 350cells /. BMC Infect Dis. 2016;16(572).
Zaw Z, Mon Y, Nandar T, Oo N, Nwe H, Aye N, et al. Survival rate and mortality risk factors among TB -HIV co-infected patients at an HIV- specialist hospital in Myanmar : A 12-year retrospective follow-up study. Int J Infect Dis [Internet]. 2019;80:10–5. doi:10.1016/j.ijid.2018.12.008
World Health Organization. WHO policy on collaborative TB / HIV activities Guidelines for national programmes and other stakeholders. Geneva, Switzerland: World Health Organization; 2012.
Telele NF, Kalu AW, Marrone G, Gebre- S. Baseline predictors of antiretroviral treatment failure and lost to follow up in a multicenter countrywide HIV-1 cohort study in Ethiopia. PLoS One. 2018;13(7):e0200505.
Wekesa P, Mcligeyo A, Owuor K, Mwangi J, Nganga E, Masamaro K. Factors associated with 36-month loss to follow-up and mortality outcomes among HIV-infected adults on antiretroviral therapy in Central Kenya. BMC Public Health. 2020;20(328):1–11.
Montessori V, Press N, Harris M, Akagi L, Montaner JSG. Adverse effects of antiretroviral therapy for HIV infection. Can Med Assoc J. 2004;170(2):229– 38.
Arya G, Arisudhana B, Achsan M, Sofro U, Sujianto U. Antiretroviral Side Effects on Adherence in People Living with HIV / AIDS. Nurse Media J Nurs. 2018;8(2):79–85.
Phillips T, Cois A, Remien RH, Mellins CA, Mcintyre A, Petro G, et al. Self-Reported Side Effects and Adherence to Antiretroviral Therapy in HIV-Infected Pregnant Women under Option B + : A Prospective Study. PLoS One. 2016;11(10).
Department Health Republic of South Africa. Adherence guidelines for HIV, TB and NCDs. South Africa: Department Health Republic of South Africa; 2016.
Enane LA, Eby J, Argabright S, Caiphus C, Kgwaadira B, Steenhoff AP, et al. TB and TB-HIV care for adolescents and young adults. Int J Tuberc Lung Dis. 2020;24(2):240–9.
Enane LA, Vreeman RC, Foster C. Retention and adherence: global challenges for the long-term care of adolescents and young adults living with HIV. Curr Opin HIV AIDS. 2018;13(3):212–9.